Patients using Acomplia report Psychiatric disorders Since the advent of the diet pill Acomplia, there have reports in Europe stating cases of psychiatric disorders, in individuals using acomplia. According to Business Week a news magazine, there are serious reports with cases related to major depression. Read More...
Acomplia has been put on hold regarding its Approval by FDA FDA {Food and drug Administration} of the U.S has decided to put Acomplia on a much slower track, and is yet to decide as to when to approve the sale of the drug in the United States, it is now set to be out only next Spring. Read More...
Acomplia approved for Sale in Mexico Paris, Nov 9 ( Reuters ) - Sanofi-Aventis having won Mexican marketing approval for Acomplia, it expects to launch the anti- obesity pill which has been put forward as a potential blockbuster, at the onset of next year. Read More...
Sweden reimburses Sanofi’s Acomplia As per the Reuters, Acomplia will be reimbursed in Sweden as an anti- obesity pill for obese and overweight patients along with health risks such as diabetes, as told by the French drug maker, Sanofi on Friday. Read More...
Acomplia- New Avenue in Diabetes Management A new study reports that diet drug Acomplia (Rimonabant) may help in controlling sugar levels in type-2 diabetes, offering a new opportunity in diabetes management.Read More...
Rimonabant (Acomplia) – Diabetes Drug Approval of Acomplia diet pills delayed further at the U.S. Acomplia is a class apart from other available diet pills. Acomplia diet pills are likely to offer multiple benefits. Apart from weight loss aspirants the miracle pill Acomplia may also play a vital role in helping smokers quit their habit of smoking. Read More...
